SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jun 10, 2026

MGX

Metagenomi Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $6K total
Actionable Insight • Neutral

These sales are routine in size and structure — no informed trading signal. Monitor the next 10-Q for cash runway updates and pipeline milestones, which are the primary drivers for this micro-cap biotech.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
MGX ▼ -4.88% at T+60d
NEUTRAL call -4.88% · α vs SPY -11.05% · entry $1.23 → $1.17
Entry = T+0 close
Jun 10, 2026
via day close
T+1d
+1.63%
call +1.63% · α -0.07%
$1.25
settled 5mo ago
T+5d
-7.32%
call -7.32% · α -10.75%
$1.14
settled 4mo ago
T+20d
+2.44%
call +2.44% · α -1.18%
$1.26
settled 4mo ago
T+60d
-4.88%
call -4.88% · α -11.05%
$1.17
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Two insiders (both See Remarks) sold a combined $5,579 in open-market sales on June 5, 2026, at $1.299/share. The aggregate dollar value is ~0.01% of MGX's $46M market cap — trivial in size and non-informative per the academic literature on insider sales (liquidity-clustering, not signal).

Key Financial Metrics

Direction
selling
Total Value
$5.6K
Insiders
2

Key Facts

  • Two insiders sold shares on 2026-06-05 at $1.299/share
  • Total open-market sales: ~$5,579 (0.012% of market cap)
  • Sales are below the <0.1% of market cap threshold for materiality
  • No C-suite officers (CEO/CFO) are in the cluster — both filers listed as 'See Remarks'
  • Cluster of sales carries no amplified informational content per Alldredge 2019; academic literature finds cluster sales not more predictive than non-cluster sales

Financial Impact

Insider sales of ~$5,579 represent 0.01% of MGX's $46M market cap — economically immaterial

dilution (insider liquidity only)

Risk Factors

  • MGX has a sub-$50M market cap with limited liquidity — even small trades can move the stock mechanically

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
78% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-MGX-1781104937094
14 reports for MGX
Performance horizon
67% Hit rate @ T+20 2 of 3 directional calls Went positive at some point 3 of 3 best @ T+20▲ +8.89%May 11, 2026
Filters
Rows
Reports for MGX — sortable, filterable
TypeNow
Sep 21, 2026
5w ago
8-K
NEUTRAL ★ 4/10
$1.14 $0.8310▼ −27.11%▼ −26.55%$0.8100 (−28.95%)
Aug 10, 2026
11w ago
8-K
BEARISH ★ 5/10
$1.21 $1.15▲ +4.96%▲ +3.90%$0.8100 (+33.06%)
Jun 10, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$1.23 $1.26▲ +2.44%▼ −1.18%$0.8100 (−34.15%)
Jun 10, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$1.23 $1.26▲ +2.44%▼ −1.18%$0.8100 (−34.15%)
Jun 10, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$1.23 $1.26▲ +2.44%▼ −1.18%$0.8100 (−34.15%)
Jun 10, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$1.23 $1.26▲ +2.44%▼ −1.18%$0.8100 (−34.15%)
Jun 10, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$1.23 $1.26▲ +2.44%▼ −1.18%$0.8100 (−34.15%)
May 11, 2026
24w ago
8-K
NEUTRAL ★ 4/10
$1.35 $1.23▼ −8.89%▼ −7.16%$0.8100 (−40.00%)
May 11, 2026
24w ago
Press Release
BEARISH ★ 6/10
$1.35 $1.23▲ +8.89%▲ +7.16%$0.8100 (+40.00%)
Apr 27, 2026
26w ago
DEFA14A
NEUTRAL ★ 2/10
$1.44 $1.36▼ −5.56%▼ −11.02%$0.8100 (−43.75%)
Showing 10 of 14

US Market Status

Market Open — Closes in 1h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 10, 2026